Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-mole...
Clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. Our patented Clean-Surface Nanosuspension™ (CSN) technology produces clean-surface nanocrystals at commercially viable rates. By coupling high-purity metallic donor materials with high-purity water, CSN unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.